Doctor profile · Federal record
Dr. Craig Neitzel, MD
Dermatology Physician (CMS: Dermatology) · Champaign, IL
- NPI 1275640617
- Accepts Medicare
- 30 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1701 W. Curtis Road, Dermatology
Champaign, IL 61822
(217) 365-6204
fax (217) 326-1234 - Mailing address
-
611 W Park St, Bwpc
Urbana, IL 618012529
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- May 7, 2014
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Illinois #036101453
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1275640617. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,848
Distinct HCPCS
9
Medicare allowed
$291,475
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 3,532 | 338 | $2 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,327 | 716 | $96 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 969 | 515 | $97 | |
17000 |
Destruction of precancer skin growth, 1 growth | 561 | 351 | $53 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 255 | 178 | $65 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 66 | 66 | $83 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 50 | 50 | $131 | |
17110 |
Destruction of skin growth, 1-14 growths | 49 | 33 | $65 | |
11102 |
Biopsy of related skin growth, first growth | 39 | 39 | $29 |
In context: peer comparison
Among 1 peers in Champaign Dermatology Physician, average services per provider: 760. This provider delivers 9.0× the peer median.Open Payments
Industry payments received
All-time total
$51,765
Transactions
169
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 42 | $25,851.75 | |
| Ucb, INC. | 17 | $15,750.93 | |
| Amgen INC. | 6 | $4,759.98 | |
| Janssen Biotech, INC. | 17 | $1,863.12 | |
| Dermavant Sciences, INC. | 18 | $1,817.11 | |
| Mayne Pharma Commercial LLC | 13 | $278.16 | |
| Arcutis Biotherapeutics, INC. | 8 | $221.09 | |
| Regeneron Healthcare Solutions, INC. | 4 | $205.92 | |
| Lilly USA, LLC | 9 | $188.68 | |
| E.R. Squibb & Sons, L.L.C. | 13 | $167.21 | |
| Genzyme Corporation | 5 | $148.70 | |
| Leo Pharma INC. | 6 | $139.86 | |
| Incyte Corporation | 4 | $100.26 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 4 | $82.40 | |
| Pfizer INC. | 3 | $62.60 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,321
Patients
728
Total drug cost
$54,797
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 329 | 204 | $6,718 |
| Clobetasol Propionate | Generic | 210 | 114 | $8,466 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 165 | 80 | $3,172 |
| Metronidazole | Generic | 120 | 65 | $6,443 |
| Ketoconazole | Generic | 84 | 35 | $1,208 |
| Clindamycin Phosphate | Generic | 79 | 38 | $3,823 |
| Desonide | Generic | 77 | 48 | $5,609 |
| Doxycycline Hyclate | Generic | 59 | 19 | $1,915 |
| Halobetasol Propionate | Generic | 51 | 26 | $3,016 |
| Tacrolimus | Generic | 43 | 31 | $11,316 |
Frequently asked questions
What is Dr. Craig Neitzel's medical specialty?
Dr. Craig Neitzel practices Dermatology Physician in Champaign, IL.
Where does Dr. Craig Neitzel practice?
Dr. Craig Neitzel practices at 1701 W. Curtis Road, Champaign, IL 61822. Office phone: 2173656204.
What is Dr. Craig Neitzel's NPI?
Dr. Craig Neitzel's National Provider Identifier (NPI) is 1275640617, issued by NPPES.
Does Dr. Craig Neitzel accept Medicare assignment?
Yes. Dr. Craig Neitzel accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Craig Neitzel commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 15 or more growths (HCPCS 17004). Source: CMS Medicare Physician & Other Practitioners file.